M1 Medulloblastoma: High risk at any age

    loading  Checking for direct PDF access through Ovid

Abstract

Background

The prognosis for children with M1 medulloblastoma (positive CSF cytology) has not been well-defined.

Methods

We retrospectively reviewed the records of 285 newly diagnosed medulloblastoma patients treated between 1984 and 2006. Older children received post-operative craniospinal and tumor bed irradiation; radiotherapy for younger children depended on treatment era and physician/family preference.

Results

55 patients were <3 years old and 230 patients were ≥ 3 years old at diagnosis. We detected significant (P < 0.0001) associations between M1 disease and EFS for the entire cohort and for both younger and older patients. Among younger children, M1 patients had lower EFS than M0 (P = 0.0044).

Conclusions

Children <3 years old with M1 medulloblastoma fared poorly in our small series. Survival for older children with M1 disease treated with higher-dose CSI was better than that of M2/M3 patients, but still less than optimal; our findings do not support reduction in therapy for either cohort.

Related Topics

    loading  Loading Related Articles